新型冠状病毒病与细菌性脓毒症循环免疫细胞谱及动力学的比较
该纵向回顾性观察研究在法国一家三级医院2020年首次新冠疫情期间,纳入247例确诊新冠患者(非重症153例、重症94例),并与108例重症脓毒症历史队列比较循环免疫细胞谱及动力学。非重症新冠免疫谱正常或轻度改变;重症新冠表现为显著且持续的淋巴细胞减少(主要为CD3、CD4、CD8及NK细胞)、中性粒细胞增多、CD14+单核细胞HLA-DR表达下调,以及独特的B细胞扩增、嗜碱性粒细胞增多和嗜酸性粒细胞增多。淋巴细胞减少、HLA-DR下调及中性粒细胞增多与不良结局相关,嗜碱性/嗜酸性粒细胞增多与生存相关。重症新冠与脓毒症免疫细胞动力学不同,ICU入住前2周免疫异常未纠正与死亡及院内感染相关。
要点
- 重症新冠(n=94)免疫谱与细菌性脓毒症不同:显著且持续的淋巴细胞减少(CD3、CD4、CD8、NK细胞)、中性粒细胞增多、CD14+单核细胞HLA-DR表达下调。
- 新冠独特表现:B细胞扩增、嗜碱性粒细胞增多、嗜酸性粒细胞增多,此三者与生存相关;淋巴细胞减少、HLA-DR下调、中性粒细胞增多与不良结局相关。
- 非重症新冠(n=153)免疫谱正常或轻度改变,重症与轻症免疫细胞谱不同。
- ICU入住前2周免疫异常未纠正与死亡及院内感染相关。
- 作者认为免疫监测可能有助于新冠患者管理。
适用人群与场景
- 2020年3月至4月法国一家三级医院急诊科、内科病房及ICU连续收治的确诊SARS-CoV-2感染患者,且住院期间至少完成一次免疫表型分析(n=247;非重症n=153,重症n=94)。
- 对照为历史队列的108例重症脓毒症患者。
研究设计与关键结果
- 研究设计:纵向回顾性观察研究,法国一家三级医院2020年首次新冠疫情期间开展。
- 纳入247例新冠患者,其中非重症153例、重症94例;对照为108例重症脓毒症历史队列。
- 非重症新冠患者免疫谱正常或轻度改变;重症新冠免疫谱与脓毒症不同。
- 重症新冠表现为显著且持续的淋巴细胞减少(主要为CD3、CD4、CD8及NK细胞)、中性粒细胞增多、CD14+单核细胞HLA-DR表达下调。
- 新冠患者呈现独特的B细胞扩增、嗜碱性粒细胞增多和嗜酸性粒细胞增多。
- 淋巴细胞减少、CD14+单核细胞HLA-DR表达下调及中性粒细胞增多与不良结局相关;嗜碱性粒细胞增多和嗜酸性粒细胞增多与生存相关。
- 重症新冠与脓毒症的循环免疫细胞动力学不同;ICU入住前2周新冠患者免疫异常未纠正与死亡及院内感染相关。
证据类型、等级与局限
- 证据类型:纵向回顾性观察研究。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为,新冠免疫监测可能有助于患者管理。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
OBJECTIVES: Although clinical presentation of coronavirus disease 2019 has been extensively described, immune response to severe acute respiratory syndrome coronavirus 2 remains yet not fully understood. Similarities with bacterial sepsis were observed; however, few studies specifically addressed differences of immune response between both conditions. Here, we report a longitudinal analysis of the immune response in coronavirus disease 2019 patients, its correlation with outcome, and comparison between severe coronavirus disease 2019 patients and septic patients.
DESIGN: Longitudinal, retrospective observational study.
SETTING: Tertiary-care hospital during the first 2020 coronavirus disease 2019 outbreak in France.
PATIENTS: All successive patients with confirmed severe acute respiratory syndrome coronavirus 2 infection admitted to the emergency department, medical ward, and ICU with at least one available immunophenotyping performed during hospital stay.
MEASUREMENTS AND MAIN RESULTS: Between March and April 2020, 247 patients with coronavirus disease 2019 were included and compared with a historical cohort of 108 severe septic patients. Nonsevere coronavirus disease 2019 patients (n = 153) presented normal or slightly altered immune profiles. Severe coronavirus disease 2019 (n = 94) immune profile differed from sepsis. Coronavirus disease 2019 exhibited profound and prolonged lymphopenia (mostly on CD3, CD4, CD8, and NK cells), neutrophilia, and human leukocyte antigen D receptor expression on CD14+ monocytes down-regulation. Surprisingly, coronavirus disease 2019 patients presented a unique profile of B cells expansion, basophilia, and eosinophilia. Lymphopenia, human leukocyte antigen D receptor expression on CD14+ monocytes down-regulation, and neutrophilia were associated with a worsened outcome, whereas basophilia and eosinophilia were associated with survival. Circulating immune cell kinetics differed between severe coronavirus disease 2019 and sepsis, lack of correction of immune alterations in coronavirus disease 2019 patients during the first 2 weeks of ICU admission was associated with death and nosocomial infections.
CONCLUSIONS: Circulating immune cells profile differs between mild and severe coronavirus disease 2019 patients. Severe coronavirus disease 2019 is associated with a unique immune profile as compared with sepsis. Several immune features are associated with outcome. Thus, immune monitoring of coronavirus disease 2019 might be of help for patient management.
参考来源
- de Roquetaillade C, Mansouri S, Brumpt C, et al. Comparison of Circulating Immune Cells Profiles and Kinetics Between Coronavirus Disease 2019 and Bacterial Sepsis. Crit Care Med. 2021. PMID: 34001691. doi:10.1097/CCM.0000000000005088
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。